SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
Molekulargewicht:
416.39
Reinheit:
98.61%
CAS Nummer:
[115621-95-9]
Formel:
C23H27Cl2N3
Target-Kategorie:
Platelet aggregation|||PAFR
T28740
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten